View in EDS

Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.

Saved in:
Bibliographic Details
Title: Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.
Authors: Alsina M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, Florida., Shah N; Division of Hematology and Oncology, University of California, San Francisco, California., Jagannath S; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Mount Sinai Medical Center, New York, New York., Kaufman JL; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Siegel D; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey., Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Rosenblatt J; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Lin Y; Mayo Clinic , Rochester, Minnesota., Jakubowiak AJ; University of Chicago , Chicago, Illinois., Derman BA; University of Chicago , Chicago, Illinois., Li A; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey., Mao P; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey., Fincker M; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey., Yeri A; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey., Martin N; Bristol Myers Squibb , Princeton, New Jersey., Campbell TB; Bristol Myers Squibb , Princeton, New Jersey., Finney O; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey., Truppel-Hartmann A; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey., Petrocca F; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey., Berdeja JG; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee., Raje N; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Source: Cancer immunology research [Cancer Immunol Res] 2026 Apr 02; Vol. 14 (4), pp. 528-542.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41562447
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Alsina+M%22">Alsina M</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Shah+N%22">Shah N</searchLink>; Division of Hematology and Oncology, University of California, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Jagannath+S%22">Jagannath S</searchLink>; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Mount Sinai Medical Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Kaufman+JL%22">Kaufman JL</searchLink>; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Siegel+D%22">Siegel D</searchLink>; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey.<br /><searchLink fieldCode="AU" term="%22Munshi+NC%22">Munshi NC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Rosenblatt+J%22">Rosenblatt J</searchLink>; Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Mayo Clinic , Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Jakubowiak+AJ%22">Jakubowiak AJ</searchLink>; University of Chicago , Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Derman+BA%22">Derman BA</searchLink>; University of Chicago , Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Li+A%22">Li A</searchLink>; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Mao+P%22">Mao P</searchLink>; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Fincker+M%22">Fincker M</searchLink>; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Yeri+A%22">Yeri A</searchLink>; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Martin+N%22">Martin N</searchLink>; Bristol Myers Squibb , Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Campbell+TB%22">Campbell TB</searchLink>; Bristol Myers Squibb , Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Finney+O%22">Finney O</searchLink>; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Truppel-Hartmann+A%22">Truppel-Hartmann A</searchLink>; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Petrocca+F%22">Petrocca F</searchLink>; 2seventy bio., a Bristol Myers Squibb Company, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Berdeja+JG%22">Berdeja JG</searchLink>; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Raje+N%22">Raje N</searchLink>; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2026 Apr 02; Vol. 14 (4), pp. 528-542.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41562447
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2326-6066.CIR-24-0527
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 528
    Titles:
      – TitleFull: Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alsina M
      – PersonEntity:
          Name:
            NameFull: Shah N
      – PersonEntity:
          Name:
            NameFull: Jagannath S
      – PersonEntity:
          Name:
            NameFull: Kaufman JL
      – PersonEntity:
          Name:
            NameFull: Siegel D
      – PersonEntity:
          Name:
            NameFull: Munshi NC
      – PersonEntity:
          Name:
            NameFull: Rosenblatt J
      – PersonEntity:
          Name:
            NameFull: Lin Y
      – PersonEntity:
          Name:
            NameFull: Jakubowiak AJ
      – PersonEntity:
          Name:
            NameFull: Derman BA
      – PersonEntity:
          Name:
            NameFull: Li A
      – PersonEntity:
          Name:
            NameFull: Mao P
      – PersonEntity:
          Name:
            NameFull: Fincker M
      – PersonEntity:
          Name:
            NameFull: Yeri A
      – PersonEntity:
          Name:
            NameFull: Martin N
      – PersonEntity:
          Name:
            NameFull: Campbell TB
      – PersonEntity:
          Name:
            NameFull: Finney O
      – PersonEntity:
          Name:
            NameFull: Truppel-Hartmann A
      – PersonEntity:
          Name:
            NameFull: Petrocca F
      – PersonEntity:
          Name:
            NameFull: Berdeja JG
      – PersonEntity:
          Name:
            NameFull: Raje N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 04
              Text: 2026 Apr 02
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2326-6074
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cancer immunology research
              Type: main
ResultId 1